Q&A: Pharmacists Play Essential Role in Insulin Therapy Success
Drug Topics
JULY 15, 2025
Pharmacists, pharmacy students, or technicians can assist with insurance navigation, advocating for prior authorizations if needed.
2025 Hospitals Insurance 
Q&A: How Advancements in GLP-1s, CGM Impact Insulin Management
Drug Topics
JULY 15, 2025
READ MORE: Insulin Advancements Led to Safer Surgeries, Shorter Hospital Stays Drug Topics : How has the administration of insulin management been impacted by medical advancements in things like CGM and GLP-1 medications? They will have insurance coverage, and that has helped tremendously to be able to adjust insulin doses.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
A closer look at how health care consolidation drives up patient costs, creates barriers to care
PhRMA
MARCH 17, 2025
Half of every dollar spent on medicines goes to entities that don’t make medicine—like pharmacy benefit managers (PBMs) and insurers who are aggressively consolidating their control over health care and hospitals, clinics and for-profit pharmacies in the 340B markup program.
Flu Vaccines Are a Go
Pharmacy Times
JULY 16, 2025
That was the question on the minds of a lot of health care professionals, public policy leaders, public health officials, and select politicians going into the first meeting of the new Advisory Committee on Immunization Practices (ACIP) in June 2025. million Medicaid, Medicare, commercially insured, and uninsured patients.
STAT+: Hospitals earn big profits, insurers face ramped up Medicare Advantage audits
STAT
MAY 27, 2025
We’ll be talking about all things Medicare Advantage. Details here on how to watch or attend! Continue to STAT+ to read the full story…
STAT+: Health care providers form a united front against stricter patient privacy rules
STAT
MARCH 7, 2025
After yet another record year for health data breaches, updated federal security rules to protect patient information are on the table in 2025.
How much do statins cost in 2025?
The Checkup by Singlecare
JUNE 16, 2025
i Price with signup Get free coupon See Atorvastatin prices at all pharmacies How much do statins cost without insurance? Does insurance cover statins ? Some insurance plans have implemented $0 copay statin options within their formulary. Sometimes it is cheaper to utilize a savings card versus insurance.
UK enacts law to decentralise manufacture of personalised treatments
Pharmaceutical Technology
JULY 23, 2025
Abigail Beaney July 23, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The new legislation will reduce the time it takes for patients to receive these therapies from months to days. Go deeper with GlobalData Reports China Contract Manufacturing Market Outlook - Trends, Ambitions, Ke.
GSK’s world-first gonorrhoea vaccine launched in England
Pharmaceutical Technology
AUGUST 5, 2025
Robert Barrie August 5, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook In 2023, a record 85,000 cases of the disease were reported in England — three times higher than in 2012. Known under the brand name Blujepa, the drug was approved in the US to treat urinary tract infections in March 2025.
How much does Forteo cost with Medicare?
The Checkup by Singlecare
AUGUST 5, 2025
Drugs administered at a hospital or outpatient clinic may be covered under Medicare Parts A or B.) Part D coverage is optional, and plans are offered by different health insurance companies like Blue Cross Blue Shield, Aetna, or Kaiser Permanente. Medicare Part D formularies vary from one health insurance company to the next.
Hengrui Pharma and GSK link across key therapeutic areas
Pharmaceutical Technology
JULY 28, 2025
July 28, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook HRS-9821 aligns with GSK’s goal to address a broad spectrum of COPD patients. In March 2025, MSD entered an exclusive licence agreement with Hengrui Pharma for the investigational oral small-molecule lipoprotein(a) [Lp(a)] inhibitor, HRS-5346.
Bharat Biotech acquires licence for GSK’s Shigella vaccine development
Pharmaceutical Technology
JUNE 13, 2025
June 13, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook GSK’s vaccine leverages GMMA technology. Give your business an edge with our leading industry insights. Give your business an edge with our leading industry insights. Thank you for subscribing View all newsletters from across the GlobalData Media network.
FDA approves Sanofi and Regeneron’s Dupixent for bullous pemphigoid
Pharmaceutical Technology
JUNE 25, 2025
June 25, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook BP is a chronic skin disease marked by severe itching, painful blisters, lesions and skin redness. In February 2025, the FDA accepted Dupixent’s supplemental biologics licence application (sBLA) for priority review. Credit: Toa55/Shutterstock.
Vutrisiran marks first silencer approved for ATTR-CM
Pharmaceutical Technology
JUNE 12, 2025
GlobalData Healthcare June 12, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook European KOLs with cardiomyopathy patients told GlobalData that they are waiting for vutrisiran’s launch for ATTR-wt. Give your business an edge with our leading industry insights. Give your business an edge with our leading industry insights.
Op-Ed: States Are Leading the Way on PBM Reform. Here’s How.
Pharmacy Times
AUGUST 1, 2025
PBMs are more powerful and influential than ever as they become extensions of major health insurers, acquire independent pharmacies, and create new business lines to funnel prescriptions through. Accessed July 23, 2025. January 14, 2025. Accessed July 23, 2025. Accessed July 23, 2025. Accessed July 23, 2025.
Pharmacists Bridge the Gaps in Care Transitions
Pharmacy Times
AUGUST 11, 2025
Transitions of care, or the movement of patients between health care settings or providers, impose a significant cost on the health care system due to frequent adverse events and hospital readmissions. Hospitals utilize pharmacists and technicians to conduct this research and reconcile patients’ medications.
Pharmacists Push Forward: Innovative Clinical Solutions Highlighted at McKesson ideaShare 2025
Pharmacy Times
JULY 12, 2025
1 Howard’s team built their telehealth service in collaboration with hospitals and health systems, especially to tackle the issue of hospital readmissions for Medicare and Medicaid patients—each of which can cost hospitals thousands of dollars.
FDA gives Arvinas and Pfizer’s vepdegestrant NDA for breast cancer
Pharmaceutical Technology
AUGUST 11, 2025
August 11, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The NDA submission was based on results from the VERITAC-2 clinical trial. Credit: Gorodenkoff/Shutterstock.com. Give your business an edge with our leading industry insights. Give your business an edge with our leading industry insights.
CNS innovator oligonucleotide licensing value up 339% from £2bn in 2024
Pharmaceutical Technology
JUNE 19, 2025
GlobalData Healthcare June 19, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The oligonucleotide market is well-positioned to drive the next wave of personalised treatment. billion from 2021 to 2025 year-to-date. Credit: Kateryna Kon via Shutterstock. ASOs accounted for more than half ($3.54
The Changing Landscape of Pharmacy Accessibility
Pharmacy Times
JULY 22, 2025
These third-party administrators act as intermediaries between drug manufacturers, pharmacies, and insurance companies. Furthermore, delays in medication access can exacerbate chronic conditions, such as diabetes, hypertension, and asthma, leading to increased hospitalization rates.
MetrioPharm gains orphan drug status from EMA for MP1032
Pharmaceutical Technology
JULY 30, 2025
July 30, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook MP1032 is intended for treating Duchenne muscular dystrophy. Credit: luchschenF/Shutterstock.com. Give your business an edge with our leading industry insights. Give your business an edge with our leading industry insights. Login Registration is disabled.
The Lifesaving Role of Continuous Glucose Monitors and Wearable Devices
Pharmacy Times
JULY 21, 2025
The most common concerns include the following 1,3-5 : • Cost and insurance barriers: Affordability remains a major barrier, as patients have difficulty accessing CGMs due to high out-of-pocket costs or limited insurance coverage. Accessed June 17, 2025. Updated February 2025. Accessed June 17, 2025. Clin Diabetes.
A Review of Oral Cephalosporins for Common Outpatient Infections
Pharmacy Times
JULY 25, 2025
John’s University – College of Pharmacy and Health Sciences and practices as an infectious diseases pharmacist at NYC Health + Hospitals/Elmhurst in Elmhurst, New York. Accessed March 2, 2025. Accessed March 5, 2025. Accessed March 5, 2025. Clinical and Laboratory Standards Institute; 2025. Accessed March 18, 2025.
Juvenescence enhances AI drug discovery with Ro5 acquisition
Pharmaceutical Technology
JUNE 6, 2025
June 6, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The funds will support clinical milestones along with AI-driven development across Juvenescence’s portfolio. The acquisition forms a key part of Juvenescence’s partnership with the Abu Dhabi global healthcare company M42, which was announced in April 2025.
Pharmacists Weigh Promise and Challenges of Finerenone for Patients With HFpEF
Pharmacy Times
JULY 24, 2025
To me, it’s positioning this in terms of how quickly these patients benefit from it, and if it’s 7 days then in my opinion, start it in the hospital.” The FDA’s Prescription Drug User Fee Act date for finerenone is in July 2025. The way that this is positioned by pharmacists is so critical,” Di Palo stressed.
Mosanna Therapeutics gains $80m to advance OSA nasal spray
Pharmaceutical Technology
JUNE 10, 2025
June 10, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The funds will be used to advance Mosanna’s nasal spray for obstructive sleep apnoea. Credit: Pixel-Shot/Shutterstock. Give your business an edge with our leading industry insights. Give your business an edge with our leading industry insights.
EC authorises Sydnexis’ paediatric myopia treatment
Pharmaceutical Technology
JUNE 6, 2025
June 6, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The authorisation in the EU signifies a step forward in eye care for paediatric patients. Credit: chaponta/Shutterstock. Give your business an edge with our leading industry insights. Give your business an edge with our leading industry insights.
STAT+: The UnitedHealth crash and mandatory Medicare models
STAT
MAY 19, 2025
A tick-tock of the 2025 UnitedHealth crash The past month has been a disastrous chain of events for UnitedHealth Group — which up until recently was a beloved stock on Wall Street. I’ve always been skeptical of virtual reality headsets, and it appears my skepticism has been justified. 09 on Signal.
Real-World Data Shows Similar Clinical Outcomes in Patients Receiving Biosimilars Following Switch From Reference Product
Pharmacy Times
JULY 4, 2025
SHOW MORE Real-world data shows patients switching from Humira to biosimilars Hadlima and Hyrimoz achieve similar outcomes without hospitalization. The research also demonstrated that no patients were hospitalized to treat their inflammatory condition during the study period.
DoH – Abu Dhabi and Sanofi link for vaccine development
Pharmaceutical Technology
JUNE 20, 2025
June 20, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The MoU was signed at the BIO International Convention 2025 in Boston, US. The MoU was signed at the BIO International Convention 2025 in Boston, in the US state of Massachusetts. Credit: Department of Health Abu Dhabi.
HS market forecast to reach $7.8bn across 7MM by 2034
Pharmaceutical Technology
JULY 28, 2025
GlobalData Healthcare July 28, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Credit: Vitalii Vodolazskyi / Shutterstock.com. CAGR is largely attributed to the launch of novel biologics and small molecules. Give your business an edge with our leading industry insights. Login Registration is disabled.
EC approves argenx’s efgartigimod alfa for CIDP treatment
Pharmaceutical Technology
JUNE 23, 2025
June 23, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook argenx is collaborating with regional regulatory authorities to facilitate patient access to the treatment. Credit: Wirestock Creators/Shutterstock. Give your business an edge with our leading industry insights. Login Registration is disabled.
Pharmacists Have a Crucial Role Helping Patients With ATTR-CM Navigate Treatment With Tafamidis
Pharmacy Times
JULY 1, 2025
Tafamidis, a selective transthyretin stabilizer, significantly reduces mortality and hospitalizations in ATTR-CM patients. Tafamidis] was compared to placebo and reduced all-cause mortality by 30% and [cardiovascular] hospitalizations by 32% over 30 months. Accessed June 30, 2025. March 21, 2025. Accessed June 30, 2025.
Semaglutide and Tirzepatide Lead the Way in Comprehensive Diabetes and Obesity Management
Pharmacy Times
JULY 23, 2025
Pharmacists are pivotal in patient counseling, therapy selection, and navigating insurance challenges, ensuring comprehensive diabetes management. She also noted the insurance considerations, including involvement with formularies and prior authorization, that come into play when making these decisions.
Managing Tardive Dyskinesia With VMAT2 Inhibitors in Clinical Practice
Pharmacy Times
JULY 28, 2025
Treatment selection is influenced by insurance, cost, and patient-specific factors due to the lack of direct RCT comparisons. At the American Association of Psychiatric Pharmacists 2025 Annual Meeting in Salt Lake City, Utah, Kayla Johnson, PharmD, BCPS, BCPP, presented on the management of TD with VMAT2 inhibitors in greater detail.
How AI Brings Pharmacogenetics to the Frontline of Precision Medicine
Pharmacy Times
JULY 22, 2025
Personalized drug selection can lead to faster symptom control, fewer hospitalizations, and improved adherence—all of which contribute to better outcomes and a more streamlined care process. Beyond improving medication safety, pharmacogenetics enhances clinical efficiency by reducing the reliance on trial-and-error prescribing.
Pharmacy Policy Updates for June 2025
Pharmacy Times
JUNE 16, 2025
3,4 How this pricing model will be implemented and whether pharmaceutical manufacturers will be able to meet the expectations of the 2025 executive order, if upheld, is uncertain. Second, it does not address the core issues of higher prices, such as the use of rebates by insurers. May 12, 2025. Accessed May 13, 2025.
Alfasigma sets stage for Jyseleca in axSpA after Phase III win
Pharmaceutical Technology
JULY 29, 2025
Abigail Beaney July 29, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The JAK1 inhibitor is already approved in RA and UC. Galapagos contributed around €40m to Alfasigma by June 2025 for Jyseleca development. Image credit: 3dMediSphere / Shutterstock.com. Sign up for our daily news round-up!
MSD receives FDA approval for Enflonsia to prevent RSV
Pharmaceutical Technology
JUNE 10, 2025
June 10, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Enflonsia is administered to infants with the same dose regardless of their bodyweight. Credit: MargJohnsonVA/Shutterstock. “We Give your business an edge with our leading industry insights. Give your business an edge with our leading industry insights.
Sanofi concludes Blueprint Medicines acquisition
Pharmaceutical Technology
JULY 21, 2025
July 21, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The acquisition of Blueprint provides Sanofi with a well-established foothold among allergists, dermatologists and immunologists. In June 2025, Sanofi agreed to acquire Blueprint for an equity value of $9.1bn. Sign up for our daily news round-up!
ADA 2025: Ready-to-Use Glucagon Empowers Diabetes Patient Safety
Pharmacy Times
JUNE 23, 2025
Goldman and Isaacs emphasize the importance of identifying at-risk patients through various health care touchpoints, including doctor's offices and pharmacies, and advocate for routine glucagon prescription and insurance coverage. But I also think everyone should have a ready-to-use cover on their insurance.
Opioid statistics, 2025
The Checkup by Singlecare
JUNE 24, 2025
American Psychiatric Association , 2025) Men are more likely to use and become dependent on opioids, but women are prescribed opioids more often than men. Morbidity and Mortality Weekly Report , 2021) Based on employer-sponsored health insurance data, individuals with OUD paid almost $12,000 in medical bills in 2018.
European pharma needs scalable models to succeed in US
Pharmaceutical Technology
JUNE 17, 2025
Abigail Beaney June 17, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook With potential tariffs and other changes in the US market, it is important for European companies to show they have a scalable model if they want to break into the market. Give your business an edge with our leading industry insights.
OTC Assessments With Recommendations and Counseling Should Be a Billable Encounter
Pharmacy Times
JUNE 17, 2025
That means that pharmacists in the twilight of their career have, at some point, filled a prescription, engaged in drug utilization review, filed insurance claims, and counseled per the Omnibus Budget Reconciliation Act of 1990 regulations for many of the products now found in front of the counter. Accessed May 5, 2025. November 2022.
Let's personalize your content